A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

Clinical trial NCT03422653 · COMPLETED

Trial details

NCT number: NCT03422653
Sponsor: Cara Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Uremic Pruritus

Start date: 2018-02-20
Primary completion: 2019-04-06
Enrollment: 378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.